EGFR‐targeted CAR‐T cells are potent and specific in suppressing triple‐negative breast cancer both in vitro and in vivo

三阴性乳腺癌 癌症研究 嵌合抗原受体 表皮生长因子受体 免疫疗法 颗粒酶B 穿孔素 乳腺癌 体内 生物 抗原 免疫学 T细胞 癌症 医学 免疫系统 CD8型 内科学 生物技术
作者
Lin Xia,Zaozao Zheng,Jun‐yi Liu,Yu‐jie Chen,Jian‐cheng Ding,Ningshao Xia,Wenxin Luo,Wen Liu
出处
期刊:Clinical & translational immunology [Wiley]
卷期号:9 (5) 被引量:79
标识
DOI:10.1002/cti2.1135
摘要

Triple-negative breast cancer (TNBC) is well known for its strong invasiveness, rapid recurrence and poor prognosis. Immunotherapy, including chimeric antigen receptor-modified T (CAR-T) cells, has emerged as a promising tool to treat TNBC. The identification of a specific target tumor antigen and the design of an effective CAR are among the many challenges of CAR-T therapy.We reported that epidermal growth factor receptor (EGFR) is highly expressed in TNBC and consequently designed an optimal third generation of CAR targeting EGFR. The efficacy of primary T lymphocytes infected with EGFR CAR lentivirus (EGFR CAR-T) against TNBC was evaluated both in vitro and in vivo. The signalling pathways activated in tumor and EGFR CAR-T cells were revealed by RNA sequencing analysis.Third-generation EGFR CAR-T cells exerted potent and specific suppression of TNBC cell growth in vitro, whereas limited cytotoxicity was observed towards normal breast epithelial cells or oestrogen receptor-positive breast cancer cells. This capability was further demonstrated in vivo in a xenograft mouse model, with minimal off-tumor cytotoxicity. Mechanistically, in vitro stimulation with TNBC cells induced the expansion of naïve-associated EGFR CAR-T cells and enhanced their persistence. Furthermore, EGFR CAR-T cells activated the interferon γ, granzyme-perforin-PARP and Fas-FADD-caspase signalling pathways in TNBC cells.We demonstrate that EGFR is a relevant immunotherapeutic target in TNBC, and EGFR CAR-T exhibits potent and specific antitumor activity against TNBC, suggesting the potential of this third-generation EGFR CAR-T as an immunotherapy tool to treat TNBC in the clinic.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
英俊寻真发布了新的文献求助10
1秒前
上官若男应助爱听歌笑寒采纳,获得10
4秒前
4秒前
star发布了新的文献求助10
5秒前
6秒前
科研通AI6.3应助酒袋采纳,获得10
6秒前
Alexbirchurros完成签到 ,获得积分0
6秒前
无极微光应助科研通管家采纳,获得20
6秒前
6秒前
上官若男应助科研通管家采纳,获得10
6秒前
慕青应助科研通管家采纳,获得30
6秒前
脑洞疼应助科研通管家采纳,获得10
7秒前
英俊寻真完成签到,获得积分10
7秒前
领导范儿应助科研通管家采纳,获得10
7秒前
我是老大应助科研通管家采纳,获得10
7秒前
7秒前
shark完成签到,获得积分20
7秒前
星辰大海应助科研通管家采纳,获得10
7秒前
领导范儿应助科研通管家采纳,获得10
7秒前
爆米花应助科研通管家采纳,获得10
7秒前
共享精神应助科研通管家采纳,获得30
7秒前
顾矜应助科研通管家采纳,获得10
7秒前
香蕉觅云应助科研通管家采纳,获得10
7秒前
7秒前
sagitar应助科研通管家采纳,获得20
8秒前
科研通AI2S应助科研通管家采纳,获得10
8秒前
一二完成签到,获得积分10
8秒前
Orange应助科研通管家采纳,获得10
8秒前
传奇3应助科研通管家采纳,获得10
8秒前
8秒前
无极微光应助科研通管家采纳,获得20
8秒前
soilman应助科研通管家采纳,获得10
8秒前
酷波er应助科研通管家采纳,获得10
8秒前
8秒前
科研通AI2S应助科研通管家采纳,获得10
8秒前
星辰大海应助科研通管家采纳,获得10
9秒前
干净的琦应助科研通管家采纳,获得30
9秒前
汉堡包应助科研通管家采纳,获得10
9秒前
CipherSage应助科研通管家采纳,获得10
9秒前
ding应助科研通管家采纳,获得10
9秒前
高分求助中
Principles of Economics, 11th Edition 10000
Prescott's Microbiology: 2026 Release ISE 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Environmental Leverage in Times of Climate Crisis: Product Standards, Carbon Border Measures and Preferential Trade Agreements 1000
Interactions of Vowel Quality and Prosody in East Slavic 1000
Erwählung und Berufung bei Paulus: Bedeutung, Entwicklung und Funktion einer Vorstellung in ihrem frühjüdischen und griechisch-römischen Kontext 850
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7190704
求助须知:如何正确求助?哪些是违规求助? 8827836
关于积分的说明 18637930
捐赠科研通 6824756
什么是DOI,文献DOI怎么找? 3175072
关于科研通互助平台的介绍 2326409
邀请新用户注册赠送积分活动 2149466